Full text is available at the source.
Abstract
Psychedelic mushrooms containing psilocybin may have therapeutic potential for treating neurological and psychiatric disorders.
- Traditional uses of psychedelic mushrooms are discussed alongside emerging research trends.
- Knowledge gaps exist in the diversity and distribution of psilocybin-containing mushrooms.
- Technologies for quantifying tryptamines and related metabolites are outlined.
- Current understanding of how psilocybin and related compounds are metabolized in humans is summarized.
- Both beneficial and hazardous health implications of psilocybin use are identified.
- Opportunities for using biotechnology and machine learning to modify metabolite profiles are explored.
Simplified